相关实验视频

Updated: Aug 17, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

基于机器学习的基因生物标志物识别,以改善肝细胞癌的预后和治疗

Lingyan Deng¹, Lei Dou², Xinyu Huang¹

¹Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan, China.

Current medicinal chemistry

|April 4, 2025

概括

这项研究确定了一种新的分子生物标志物,即HCC预后相关指数 (HPRI),用于预测结果并指导肝细胞癌 (HCC) 患者的个性化治疗.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
生物信息学是一种生物信息学.

背景情况:

肝细胞癌 (HCC) 的预后是传统方法很难预测的.
需要新的分子生物标志物来改善患者管理.

研究的目的:

确定一种强大的分子生物标志物,用于预测HCC的预后.
开发一种指导HCC患者个性化治疗的工具.

主要方法:

综合分析多队列基因表达数据 (ICGC,GEO,TCGA).
应用机器学习来识别HCC中的关键预后基因.
开发和验证了使用名录模型的HCC预后相关指数 (HPRI).
评估与HPRI相关的瘤微环境和药物敏感性.

主要成果:

鉴定了七个关键的预后基因 (DCAF13,EEF1E1,GMPS,OLA1,PLOD2,PABPC1,PPARGC1A) 对于HCC.
验证了HPRI及其名录模型,用于跨队列的预测性能.
高HPRI与免疫逃避有关,并可能从特定的化疗中获益 (索拉费尼布,ML323,MK-1775).

结论:

HPRI是HCC预后的一个有前途的生物标志物.
HPRI有助于指导肝细胞癌的个性化治疗策略.
综合分析为瘤学中的生物标志物发现提供了强大的框架.

关键词:

肝细胞癌 (HCC) 是一种肝细胞癌.药物敏感性药物敏感性免疫疗法免疫疗法机器学习是机器学习.预后预后预后瘤微环境是一个微环境.

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...